Physician

Alejandro A Inclan, MD

According to 2025 Medicare claims, Alejandro Inclan, MD (NPI: 1023003456) practices hematology/oncology in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is WOODLANDS MEDICAL SPECIALISTS P A (NPI: 1225274772; TIN: 261802830) and primary practice location at 32503-2339. Inclan is affiliated with the Aledade 154 FL GA MSSP Enhanced (ACO ID: A5357), participating under the MSSP model.

Inclan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 288 traditional Medicare patients, billed 43,644 HCPCS/CPT codes, and received $1,540,156 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 481 prescription claims across 94 beneficiaries totaling $1,192,665 in drug costs, led by Revlimid (Lenalidomide). DME data shows 15 claims. Open Payments data shows 11 records totaling $242. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,097,832 and ending at $1,192,665. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	782	78,254	$1,145,223
2016	821	101,611	$1,268,912
2017	862	172,823	$1,861,702
2018	754	152,120	$1,928,441
2019	716	184,607	$2,554,404
2020	516	81,273	$2,063,436
2021	460	57,613	$1,462,284
2022	384	54,226	$1,377,357
2023	344	46,523	$1,488,004
2024	288	43,644	$1,540,156

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	168	1,287	$1,097,832
2016	147	1,146	$1,346,208
2017	136	1,003	$1,272,514
2018	119	835	$779,625
2019	116	679	$758,787
2020	109	586	$995,354
2021	92	468	$1,112,528
2022	88	442	$1,113,807
2023	90	438	$671,304
2024	94	481	$1,192,665

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	116	$41,797
2016	12	67	$18,931
2017	14	83	$18,587
2018	N/R	89	$11,348
2019	12	41	$5,561
2020	N/R	11	$1,503
2021	N/R	11	$1,531
2022	N/R	15	$1,898
2023	N/R	N/R	N/R
2024	14	15	$2,869

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	55	212	$135
77066	Diagnostic mammography of both breasts	53	53	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	238	753	$90
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	80	86	$35
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	243	650	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	16	448	$315,743
Ibrance	Palbociclib	17	476	$290,586
Xtandi	Enzalutamide	11	330	$160,111
Eliquis	Apixaban	23	690	$13,507
Exemestane	Exemestane	18	1,260	$5,596

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	14	15	$2,869

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$242	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alejandro A. Inclan, MD?

Tedicare shows public-source Medicare data for Alejandro A. Inclan, MD (NPI 1023003456), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alejandro A. Inclan, MD have ACO affiliation data?

Alejandro A. Inclan, MD is shown with ACO affiliation data for Aledade 154 FL GA MSSP Enhanced (MSSP, ACO ID A5357).

What billing organization is linked to Alejandro A. Inclan, MD?

Alejandro A. Inclan, MD is linked to WOODLANDS MEDICAL SPECIALISTS P A (billing NPI 1225274772) in the available physician profile data.

Does Alejandro A. Inclan, MD have Open Payments data?

Alejandro A. Inclan, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.